Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark Worthington currently holds 300,000 shares of Athira Pharma, Inc. (ATHA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Worthington has been a net seller of ATHA stock. They have purchased $0 and sold $38.1K worth of shares.
Mark Worthington's most recent insider trade was on Apr 9, 2026, when they sold 300,000 shares at $0.00 per share.
Mark Worthington serves as Executive at Athira Pharma, Inc. (ATHA). They have executed 24 insider transactions totaling $38.1K over their tenure at the company.
Mark Worthington holds the position of Executive at Athira Pharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Mark Worthington has shown a selling trading pattern, with $0 in total purchases and $38.1K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark Worthington was on May 18, 2022, when they purchased $24.0K worth of ATHA shares. This transaction involved 3,396 shares at $7.06 per share.
Mark Worthington currently owns 300,000 shares of Athira Pharma, Inc. (ATHA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark Worthington's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark Worthington has 24 Form 4 filings on record as an insider at Athira Pharma, Inc..
Set alerts for Mark Worthington and 40,000+ other insiders.